Buchumschlag

Economic Aspects in the Management of Diabetic Macular Edema in Italy

BackgroundDiabetic Macular Edema (DME) is the most common cause of vision loss in diabetic patients. Currently, the Vascular Endothelial Growth Factor inhibitors (anti-VEGFs) are used as the first line of DME treatment and corticosteroid implants are usually used as a second-line treatment. These im...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Giovanna Elisa Calabrò (VerfasserIn), Michele Basile (VerfasserIn), Monica Varano (VerfasserIn), Filippo Amore (VerfasserIn), Roberto Ricciardi (VerfasserIn), Francesco Bandello (VerfasserIn), Americo Cicchetti (VerfasserIn)
Format:	Buch
Veröffentlicht:	Frontiers Media S.A., 2022-07-01T00:00:00Z.
Schlagworte:	article
Online-Zugang:	Connect to this object online.
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy
von: Giovanna Elisa Calabrò, et al.
Veröffentlicht: (2024)

Edema macular cistoideo Macular cystoid edema
von: Blanca Nieve Rey Estévez, et al.
Veröffentlicht: (2010)

Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention
von: Giovanna Elisa Calabrò, et al.
Veröffentlicht: (2022)

The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach
von: Giovanna Elisa Calabro', et al.
Veröffentlicht: (2022)

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
von: Andrea Russo, et al.
Veröffentlicht: (2013)

Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study
von: Kyungseon Choi, et al.
Veröffentlicht: (2024)

Developing an Evidence-Based Tool for Planning and Evaluating Vaccination Strategies Aimed at Improving Coverage in Elderly and At-Risk Adult Population
von: Giovanna Elisa Calabrò, et al.
Veröffentlicht: (2021)

Update in treatment of uveitic macular edema
von: Koronis S, et al.
Veröffentlicht: (2019)

Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus
von: Roberta Spinetta, et al.
Veröffentlicht: (2023)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
von: Lorenzo Ferro Desideri, et al.
Veröffentlicht: (2023)

Macular Edema: The Current Recommendations for Clinical Practice
Veröffentlicht: (2022)

Cystoid Macular Edema: Causes, Diagnosis and Treatment
von: Noelia Bravo-Alcobendas, et al.
Veröffentlicht: (2015)

The role of aflibercept in the management of diabetic macular edema
von: Chang AA, et al.
Veröffentlicht: (2015)

Some considerations about the diabetic macular edema
von: Blanca Nieve Rey Estevez, et al.
Veröffentlicht: (2017)

The Evolving Treatment Options for Diabetic Macular Edema
von: Atul Jain, et al.
Veröffentlicht: (2013)

Effectiveness of a Hydrophilic Curcumin-Based Formulation in Coadjuvating the Therapeutic Effect of Intravitreal Dexamethasone in Subjects With Diabetic Macular Edema
von: Mariacristina Parravano, et al.
Veröffentlicht: (2022)

Widening use of dexamethasone implant for the treatment of macular edema
von: Bonfiglio V, et al.
Veröffentlicht: (2017)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
von: Cai S, et al.
Veröffentlicht: (2018)

Algunas consideraciones sobre el edema macular diabético
von: Blanca Nieve Rey Estevez, et al.

Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
von: Brent Siesky, et al.
Veröffentlicht: (2012)

Etiology and treatment of the inflammatory causes of cystoid macular edema
von: Hyung Cho, et al.
Veröffentlicht: (2009)

Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy
von: Rossella Di Bidino, et al.
Veröffentlicht: (2020)

Long-term care insurance in Italy: medico-legal and socio-economic profiles
von: Paolo Bailo, et al.
Veröffentlicht: (2024)

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
von: Messenger WB, et al.
Veröffentlicht: (2013)

Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
von: Jesus H. Gonzalez-Cortes, et al.
Veröffentlicht: (2022)

Pharmacoeconomic analysis of anti-angiogenic therapy for diabetic macular edema
von: S. V. Nedogoda, et al.
Veröffentlicht: (2019)

Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
von: A. E. Cheberda, et al.
Veröffentlicht: (2018)

A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification
von: Alessia Tognetto, et al.
Veröffentlicht: (2017)

Advancements in the Treatment of Diabetic Macular Edema: Current Strategies and Future Directions
von: Zuzanna Czach, et al.
Veröffentlicht: (2024)

Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis
von: Yu Lin, et al.
Veröffentlicht: (2022)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
von: Kim M
Veröffentlicht: (2016)

Investigation of the Reproducibility of Portable Optical Coherence Tomography in Diabetic Macular Edema
von: Yoshiaki Chiku, et al.
Veröffentlicht: (2024)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Diabetic Macular Edema
von: Thibaud Mathis, et al.
Veröffentlicht: (2023)

Features of aflibercept plus hyperbaric oxygen therapy for diabetic macular edema
von: V. O. Drozdov, et al.
Veröffentlicht: (2022)

Changes in clinical and biochemical characteristics in combination treatment for diabetic macular edema
von: V. O. Drozdov, et al.
Veröffentlicht: (2022)

The Role of Inflammation in the Pathogenesis of Macular Edema Secondary to Retinal Vascular Diseases
von: Francisco J. Ascaso, et al.
Veröffentlicht: (2014)

Knowledge, attitudes, and behaviors toward COVID-19 vaccination in a sample of Italian healthcare workers
von: Luca Regazzi, et al.
Veröffentlicht: (2022)

The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy
von: Entela Xoxi, et al.
Veröffentlicht: (2021)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
von: Ilda Hoxhaj, et al.
Veröffentlicht: (2022)

Criteria of severity for macular edema associated with retinal vein occlusion: cohort heterogeneity and efficacy evaluation of threshold and subthreshold retinal laser photocoagulation depending on the macular edema severity criteria. Part II.
von: T.O. Romanova
Veröffentlicht: (2017)